Matches in Nanopublications for { ?s ?p "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP319384.RAlIQZN-C8kklY024Ho_gkGj4MXMwtD6Rc_txtgCgWwt8130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319384.RAlIQZN-C8kklY024Ho_gkGj4MXMwtD6Rc_txtgCgWwt8130_provenance.
- NP332248.RAlGvOI11PjTq7Zd2ojWV7nnYN_MEmed5mXQKbOyXGbaA130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332248.RAlGvOI11PjTq7Zd2ojWV7nnYN_MEmed5mXQKbOyXGbaA130_provenance.
- NP594043.RAHcG0Aj8wnu4OlRoLc77Oe5DHMXApjSKmiRP1bqtuSlI130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594043.RAHcG0Aj8wnu4OlRoLc77Oe5DHMXApjSKmiRP1bqtuSlI130_provenance.
- NP714274.RAwSCvohfwkWNmTT3LlTHJF95-teLOONmmAwhZVDWVfHc130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714274.RAwSCvohfwkWNmTT3LlTHJF95-teLOONmmAwhZVDWVfHc130_provenance.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_provenance.
- assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP714636.RAlwvSM4-TVbVeW6w6shKbDXbT_cYK4BwT4ae5lD9G_54130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714636.RAlwvSM4-TVbVeW6w6shKbDXbT_cYK4BwT4ae5lD9G_54130_provenance.
- NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276252.RAih6YbvRnbmsa_D_k4CWr_Oxf8vKbdlxKeeMtpgEYpkk130_provenance.